Joseph Gilliam
President chez GLAUKOS CORPORATION
Fortune : 10 M $ au 31/03/2024
Profil
Joseph E.
Gilliam's current jobs include being a Director at Avedro, Inc. since 2019, a Director at Caris Life Sciences, LLC since 2021, and the President & Chief Operating Officer at Glaukos Corp.
since 2017.
Previously, he worked as a Managing Director-Healthcare Investment Banking at JPMorgan Chase & Co. from 2001 to 2017.
He completed his undergraduate degree at Kelley School of Business in 1998.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GLAUKOS CORP
0,21% | 08/04/2024 | 101 845 ( 0,21% ) | 10 M $ | 31/03/2024 |
Postes actifs de Joseph Gilliam
| Sociétés | Poste | Début |
|---|---|---|
| GLAUKOS CORPORATION | President | 01/04/2022 |
| AVEDRO, INC. | Director/Board Member | 21/11/2019 |
Caris Life Sciences, LLC
 Caris Life Sciences, LLC Medical/Nursing ServicesHealth Services Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX. | Director/Board Member | 12/04/2021 |
Anciens postes connus de Joseph Gilliam
| Sociétés | Poste | Fin |
|---|---|---|
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01/05/2017 |
Formation de Joseph Gilliam
| Kelley School of Business | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| JPMORGAN CHASE & CO. | Finance |
| GLAUKOS CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Avedro, Inc.
 Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
Caris Life Sciences, LLC
Caris Life Sciences, LLC Medical/Nursing ServicesHealth Services Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX. | Health Services |
